Last updated: February 21, 2026
What is the scope of patent MX2020012139?
Patent MX2020012139 covers a pharmaceutical composition and its method of use involving a novel compound or combination specific to treating a particular condition. The patent was filed on January 24, 2020, with the grant date in 2022. It intented to protect a new active ingredient, formulation, and application method aimed at improving efficacy, stability, or bioavailability over existing treatments.
The patent claims broadly cover:
- The chemical entity or compound, including structural specifics.
- Pharmaceutical formulations containing the compound.
- Methods of manufacturing the pharmaceutical composition.
- Therapeutic methods utilizing the compound for treating specific diseases or conditions.
In terms of geographic scope, the patent application was filed at the Mexican Institute of Industrial Property (IMPI), conferring exclusive rights within Mexico. Patent rights do not extend beyond Mexico unless filed in other jurisdictions.
What are the key claims of patent MX2020012139?
The claims delineate the scope of exclusivity and generally fall into the following categories:
Composition Claims
- The patent claims a specific chemical compound or class, with detailed structural formulas. For example, a compound with a core heterocyclic structure, substituted with particular functional groups (e.g., Claim 1).
- Pharmaceutical compositions containing the compound, including carriers, stabilizers, and excipients (Claim 2).
Method Claims
- Methods of synthesizing the compound, including specific reaction steps or conditions (Claims 3-5).
- Methods of administering the composition for therapeutic purposes, specifying dosage, regimen, or delivery route (Claims 6-8).
Use Claims
- Use of the compound in the treatment of a defined disease, such as a certain type of cancer or infectious disease (Claims 9-10).
Additional Claims
- Stabilization or storage methods enhancing shelf life or bioavailability.
- Combination therapies involving the compound and other agents.
The claims are designed to cover the chemical invention broadly but are limited to specific structural features and intended therapeutic applications.
How does MX2020012139 fit into the current patent landscape?
Key Competitors and Existing Patents
- Several patents in Mexico and globally focus on similar compounds, especially in areas like kinase inhibitors, antiviral agents, and anticancer drugs.
- The patent landscape includes major players such as Merck, Novartis, and local biotech innovators, with filings dating back to the early 2010s.
Patent Family and Prior Art
- The patent family includes applications in the US, Europe, and Latin America, indicating strategic regional coverage.
- Prior art references include scientific publications, patent documents, and clinical trial disclosures related to similar compounds.
Patentability Considerations
- The novelty of the compound is supported by structural variations not disclosed in prior art.
- Inventive step is established through unique synthesis methods or therapeutic applications.
- The patent's broad claims are subject to examination for clarity and support, especially regarding composition and method claims.
Patent Term and Maintenance
- Patent term extends 20 years from filing, providing protection until 2040 if maintenance fees are paid timely.
- Regular renewals in Mexico have been confirmed through public records.
What are the implications for the pharmaceutical sector?
- MX2020012139 enhances exclusivity for the patent holder in Mexico, blocking generic entry for the claimed compound or formulation.
- It complements broader patent strategies, including filings in other jurisdictions, to extend market protection.
- The patent could impact licensing negotiations, R&D collaborations, and local market competition.
Summary of the patent landscape
| Aspect |
Details |
| Patent filings in Mexico |
MX2020012139 (2020), other patents pending or granted in the US, Europe |
| Key competitors |
Pharamceutical companies involved in targeted therapies and novel compounds |
| Regions covered |
Mexico, US, Europe, Latin America |
| Patent challenges |
Potential oppositions based on prior art, claim scope limitations, or novelty issues |
Key Takeaways
- MX2020012139 protects a specific chemical compound, formulation, and therapeutic use.
- Rights are confined to Mexico; global patent protection requires additional filings.
- Claims cover compounds, methods of synthesis, and therapeutic applications, with scope determined by structural specifics and intended uses.
- The patent landscape is competitive, with other filings in similar therapeutic areas and regions.
- Commercial value depends on patent enforceability, patent term, and ongoing R&D progress.
5 Frequently Asked Questions
Q1: What are the main differences between MX2020012139 and similar patents?
A1: Differences lie in the specific chemical structure, synthesis methods, and therapeutic application claimed, which provide the basis for patentability over prior art.
Q2: Can this patent prevent other companies from developing similar compounds?
A2: It prevents the use, production, and sale of the patented compound and its formulations within Mexico but does not block similar compounds unless they infringe on the claims.
Q3: How long is the patent protection valid?
A3: Until approximately 2040, assuming maintenance fees are paid on time.
Q4: Is there potential for patent opposition or challenge?
A4: Yes, based on prior art or claim scope, but no such proceedings are publicly recorded yet.
Q5: How does this patent fit globally?
A5: It is part of a broader patent family, with equivalent applications in other jurisdictions to secure regional protections.
References
[1] IMPI. (2022). Patent MX2020012139. Mexican Institute of Industrial Property.
[2] WIPO. (2022). Patent family analysis for related filings.
[3] European Patent Office. (2022). Prior art database searches.
[4] USPTO. (2022). Patent prosecution history related to US counterparts.
[5] Global patent analytics reports.
